• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP IMPLANTABLE PORT, GROSHONG, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP IMPLANTABLE PORT, GROSHONG, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number CP00003
Device Problems Fluid/Blood Leak (1250); Fracture (1260); Deformation Due to Compressive Stress (2889); Naturally Worn (2988)
Patient Problem Extravasation (1842)
Event Date 02/22/2024
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text: device not returned.
 
Event Description
It was reported that sometime post a port placement, the port was allegedly found to be fractured.It was further reported that the mid portion of the catheter allegedly leaked.Furthermore, the patient allegedly experienced extravasation as the chemo leaked into the soft tissue.Reportedly, the port was replaced.The current status of the patient was unknown.
 
Event Description
It was reported that one year, six months and thirteen days post a port placement in right internal jugular vein the catheter was allegedly found to be completely fractured.It was further reported that the mid portion of the catheter allegedly leaked towards the entry site at the jugular.Furthermore, the patient allegedly experienced extravasation as the chemo leaked into the soft tissue.Reportedly, the port was removed and replaced.The current status of the patient was unknown.
 
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H10: d4 (expiry date: 01/2024), g3, h6 (device) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one power port implantable port attached to a groshong catheter in two segments were returned for evaluation.Visual, microscopic, tactile and functional evaluations were performed on the returned device.A partial circumferential break was noted from the proximal end of the distal catheter segment.The edges of the partial circumferential break were noted to be uneven, and the surface was noted to be round and smooth in both regions.Upon infusion, a leak from the partial circumferential break on the catheter was observed.Kinks were noted throughout the distal catheter segment.Therefore, the investigation is confirmed for the reported fracture, fluid leak and the identified deformation and catheter wear issues.The break is typical of flexural fatigue, which is due to the repetitive, cyclic kinking, of the catheter.A definitive root cause could not be determined based upon the available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that approximately one year, six months and thirteen days post a port placement in the right internal jugular vein, an alleged leak was identified via a venogram through the exiting catheter, towards the entry site, causing fluid to leak into the patient¿s soft tissue.It was further reported that the catheter was also observed to be completely fractured.The device was reportedly exchanged under fluoroscopy guidance and the procedure was completed without complications or significant blood loss.The patient recovered and was discharged home later that same day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT ISP IMPLANTABLE PORT, GROSHONG, 8F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18948194
MDR Text Key338187102
Report Number3006260740-2024-01177
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081311
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility,Company Representative
Reporter Occupation Risk Manager
Type of Report Initial,Followup,Followup
Report Date 05/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCP00003
Device Lot NumberREGS1968
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/22/2024
Initial Date FDA Received03/21/2024
Supplement Dates Manufacturer Received04/24/2024
Not provided
Supplement Dates FDA Received05/21/2024
05/31/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexFemale
Patient Weight61 KG
Patient RaceWhite
-
-